In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and decreased the expression of a ...

Se og Hor reported a sighting of the royal boarding a flight from Gardermoen to London at 1pm with Marius Borg Høiby, 27, who ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

Good afternoon and welcome to the Trevi Therapeutics3rd Quarter, 2024 earnings conference call. At this time, all participants will be in listen-only mode. (Operator Instruction) Please note this ...

Q3 2024 Earnings Call Transcript November 7, 2024 MannKind Corporation beats earnings expectations. Reported EPS is $0.05, ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsMichael Castagna - CEOChris Prentiss ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

reversing the 180 mL decline over that period that would typically be observed in untreated IPF patients. The drug – taken orally twice a day – was also safe and well-tolerated over 36 weeks ...

MannKind will host a conference call and presentation webcast to discuss these results today at 4:30 p.m. Eastern Time. The webcast will be accessible via a link on MannKind’s website. A replay will ...

Don Bosseler, an All-American fullback who led Miami to the No. 6 ranking in The Associated Press poll in 1956 and was ...

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...